| Sample | Tyrosinase inhibition (%) | DOPA inhibition (%) |
|---|---|---|
| 19±1.08 | 13±2.59 | |
| 17±2.84 | 3±6.60 | |
| 9±0.24 | 2±3.92 | |
| 14±0.44 | 3±6.94 | |
| 16±3.68 | - | |
| 24±5.60 | - | |
| 10±3.51 | - | |
| 17±2.32 | - | |
| 13±2.39 | 5±1.81 | |
| 42±5.10 | - | |
| - | 13±1.31 | |
| 21±1.40 | 7±8.83 | |
| 16±2.72 | 11±9.25 | |
| 26±3.99 | 13±1.97 | |
| 11±8.38 | - | |
| 2±3.68 | 10±2.88 | |
| 9±2.39 | 7±0.65 | |
| 21±1.29 | - | |
| 6±1.96 | 73±9.49 | |
| 18±2.36 | - | |
| 10±2.03 | 8± 12.59 | |
| 24±3.29 | - | |
| 10±2.07 | 12±3.95 | |
| 25±1.48 | 6±8.20 | |
| 17±2.05 | 20±0.73 | |
| 17±4.55 | 7±7.31 | |
| 25±1.71 | 29±6.58 | |
| 15±4.16 | - | |
| 25±6.51 | - | |
| 3±5.96 | 11±8.32 | |
| 30±4.26 | - | |
| 40±1.55 | 0±17.77 | |
| 60±4.60 | 33±4.20 | |
| 11±0.25 | 13±6.81 | |
| 11±2.75 | 4±4.03 | |
| 17±2.43 | - | |
| 17±2.90 | 11±6.35 | |
| 3± | - |